Expanded Hereditary Cancer Genetic Testing

Overview

About this study

The purpose of this study is to measure the clinical impact of re-testing (quantifying the percentage of those who subsequently test positive, which genes are identified, and quantifying the percentage of those who have not received recommended clinical management as well as those for whom new clinical management options exist).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patients over the age of 18.
Must be competent.
Able to provide oral consent.

Exclusion Criteria:

Under the age of 18.
Non-competent.
Patient refusal to participate in research studies at Mayo Clinic.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Jacksonville, Fla. Mayo Clinic principal investigator Stephanie Hines, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Stephanie Hines, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials